Join
Live feed
·
INSIDERFilingvia Quantisnow
Dicerna Pharmaceuticals, Inc. logo

SEC Form 4: Zeng Ling converted options into 2,562 shares and covered exercise/tax liability with 752 shares, increasing direct ownership by 56% to 5,032 units (withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DRNA (Dicerna Pharmaceuticals, Inc.) and more on Quantisnow.

SEC Form 4: Zeng Ling converted options into 2,562 shares and covered exercise/tax liability with 752 shares, increasing direct ownership by 56% to 5,032 units (withholding tax) | Quantisnow